Last reviewed · How we verify

NCT05636345

An Evaluation of a Public Health Campaign in a High School Setting Targeting Pain Related Knowledge and Beliefs

Completed NA Last updated 12 January 2023
What this trial tests

NA trial testing pain science education in Pain, Chronic in 90 participants. Completed in 17 March 2022.

Timeline
17 March 2022
Primary endpoint
17 March 2022
17 March 2022

Quick facts

Lead sponsorTeesside University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment90
Start date17 March 2022
Primary completion17 March 2022
Estimated completion17 March 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Teesside University

Who can join

16 and older, any sex, with Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The beliefs held by students lead to behaviours in response to their pain which can be both helpful or a hindrance to how they manage their pain. The one-day education event aims to educate the cohort on the contemporary scientific understanding of persistent pain. It is hoped this event will result in an improvement in the alignment of beliefs and behaviours to contemporary understanding of persistent pain. The principal aim is to evaluate the pre-post beliefs about pain following a one-day pain education event.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Teesside University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05636345.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing